EVOK logo

Evoke Pharma, Inc.


EVOK: Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.


Show EVOK Financials

Consumer Interest
SEC Filings

Recent trades of EVOK by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by EVOK's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Nasal formulations of metoclopramide Apr. 18, 2023
  • Patent Title: Treatment of moderate and severe gastroparesis Dec. 06, 2022
  • Patent Title: Nasal formulations of metoclopramide Jun. 01, 2021
  • Patent Title: Nasal formulations of metoclopramide Dec. 18, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of EVOK in WallStreetBets Daily Discussion


Recent insights relating to EVOK

CNBC Recommendations

Recent picks made for EVOK stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in EVOK

Corporate Flights

Flights by private jets registered to EVOK